Variables | Vitamin K2 group (n = 32) | Placebo group (n = 31) | Between group p-value3 | Adjusted p-value4 |
---|---|---|---|---|
Castelli index Ӏ2 | ||||
After 12-week | 3.29 ± 0.75 | 3.67 ± 0.91 | 0.073 | 0.333 |
Mean change from baseline | – 0.04 ± 0.45 | 0.02 ± 0.55 | 0.657 | – |
Within group P-value5 | 0.657 | 0.834 | – | – |
Triglycerides / HDL-C ratio | ||||
After 12-week | 2.81 ± 1.94 | 3.74 ± 2.25 | 0.083 | 0.252 |
Mean change from baseline | −0.10 ± 0.71 | − 0.01 ± 0.51 | 0.570 | – |
Within group P-value5 | 0.442 | 0.925 | – | – |
AC6, 7 | ||||
After 12-week | −0.21 ± 0.45 | 0.02 ± 0.43 | 0.043 | 0.167 |
Mean change from baseline | −0.03 ± 0.25 | 0.01 ± 0.21 | 0.407 | – |
Within group P-value5 | 0.440 | 0.709 | – | – |
Castelli index ӀӀ8 | ||||
After 12-week | 1.69 ± 0.41 | 1.88 ± 0.54 | 0.132 | 0.264 |
Mean change from baseline | 0.02 ± 0.30 | 0.07 ± 0.38 | 0.506 | – |
Within group P-value5 | 0.777 | 0.297 | – | – |
TyG-Index | ||||
After 12-week | 8.88 ± 0.55 | 9.23 ± 0.69 | 0.029 | 0.084 |
Mean change from baseline | −0.14 ± 0.46 | 0.0005 ± 0.42 | 0.205 | – |
Within group P-value5 | 0.091 | 0.995 | – | – |
AIP | ||||
After 12-week | 0.37 ± 0.27 | 0.51 ± 0.24 | 0.031 | 0.135 |
Mean change from baseline | −0.03 ± 0.15 | 0.003 ± 0.12 | 0.325 | – |
Within group P-value5 | 0.245 | 0.901 | – | – |
METS-IR | ||||
After 12-week | 43.1 ± 8.42 | 45.2 ± 7.29 | 0.292 | 0.067 |
Mean change from baseline | −0.80 ± 2.24 | 0.15 ± 2.30 | 0.101 | – |
Within group P-value5 | 0.052 | 0.719 | – | – |
LCI7 | ||||
After 12-week | 1.91 ± 0.34 | 2.04 ± 0.43 | 0.194 | 0.315 |
Mean change from baseline | 1.34 ± 0.57 | 1.54 ± 0.53 | 0.167 | – |
Within group P-value5 | 0.391 | 0.842 | – | – |